Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04487587
Title A Phase II Clinical Trial of Cediranib and Olaparib Maintenance in Advanced Recurrent Cervical Cancer (COMICE)
Recruitment Unknown status
Gender female
Phase Phase II
Variant Requirements No
Sponsors The Clatterbridge Cancer Centre NHS Foundation Trust

cervix carcinoma

cervical squamous cell carcinoma

cervical adenocarcinoma

cervical adenosquamous carcinoma


Cediranib + Olaparib

Age Groups: adult | senior
Covered Countries

No variant requirements are available.